Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022;95(5):405-414.
doi: 10.1159/000524030. Epub 2022 Mar 10.

Care for Transgender Young People

Affiliations
Review

Care for Transgender Young People

Damian Krebs et al. Horm Res Paediatr. 2022.

Abstract

Clinicians of all disciplines, including pediatric endocrinologists, are likely to encounter transgender and gender-diverse (TGD) young people in their practice regardless of whether they specialize in gender-affirming medical care. Because of this, it is important to be aware of the ways in which medical professionals can affirm these individuals. Although gender-affirming therapy should always include affirmation including proper use of names and pronouns, the transition journey will look different for each patient. The gender-affirming care of TGD young people may include both medical and nonmedical interventions (e.g., social transition). Therapies utilized for medical gender transition such as gonadotropin-releasing hormone agonists and/or gender-affirming hormones have implications for growth, bone health, cardiovascular health, and fertility, although these impacts are not yet completely understood. This review provides an overview of the care of transgender young people as well as a summary of what is known about the outcomes of these therapies. Clinicians should advise TGD young people and their families of the known and unknown risks and work together with patients to decide upon a treatment and follow-up regimen that aligns with their individual gender affirmation and health goals.

Keywords: Gender-affirming care; Gender-affirming hormones; Pediatric care; Puberty blockers; Transgender and gender-diverse youth.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Statement: The authors have no conflicts of interest to declare.

References

    1. Butler G, de Graaf N, Wren B, Carmichael P. Assessment and support of children and adolescents with gender dysphoria. Archives of Disease in Childhood 2018;103:631–6. 10.1136/archdischild-2018-314992. - DOI - PubMed
    1. Kidd KM, Sequeira GM, Douglas C, Paglisotti T, Inwards-Breland DJ, Miller E, et al. Prevalence of gender-diverse youth in an urban school district. Pediatrics 2021; 147. 10.1542/PEDS.2020-049823. - DOI - PMC - PubMed
    1. Johns MM, Lowry R, Andrzejewski J, Barrios LC, Demissie Z, McManus T, et al. Transgender Identity and Experiences of Violence Victimization, Substance Use, Suicide Risk, and Sexual Risk Behaviors Among High School Students — 19 States and Large Urban School Districts, 2017. MMWR Morbidity and Mortality Weekly Report 2019;68:67–71. 10.15585/mmwr.mm6803a3. - DOI - PMC - PubMed
    1. Fast AA, Olson KR. Gender Development in Transgender Preschool Children. Child Development 2018;89:620–37. 10.1111/CDEV.12758. - DOI - PubMed
    1. Ristori J, Steensma TD. Gender dysphoria in childhood. International Review of Psychiatry 2016;28:13–20. 10.3109/09540261.2015.1115754. - DOI - PubMed